| UniProt ID | PLS2_HUMAN | |
|---|---|---|
| UniProt AC | Q9NRY7 | |
| Protein Name | Phospholipid scramblase 2 | |
| Gene Name | PLSCR2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 297 | |
| Subcellular Localization |
Membrane Single-pass type II membrane protein. Isoform 1: Nucleus . |
|
| Protein Description | May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. May play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system.; Isoform 1 has no prospholipid scramblase activity, due to the lack of a N-terminal proline-rich domain.. | |
| Protein Sequence | MRSWNSLFCLNSSRPPGHIVYPKHQAGHTGKQADHLGSQAFYPGRQHDYLVPPAGTAGIPVQNQPGRPEGVPWMPAPPPPLNCPPGLEYLSQIDMILIHQQIELLEVLFSFESSNMYEIKNSFGQRIYFAAEDTNFCIRNCCGRSRPFTLRITDNVGREVITLERPLRCNCCCCPCCLQEIEIQAPPGVPVGYVTQTWHPCLTKFTIKNQKREDVLKISGPCIVCSCIAGVDFEITSLDEQIVVGRISKHWSGFLREAFTDADNFGIQFPRDLDVKMKAVMIGACFLIDYMFFERTR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 13 | Phosphorylation | SLFCLNSSRPPGHIV CEEECCCCCCCCEEE | 19.11 | 28464451 | |
| 47 | Ubiquitination | AFYPGRQHDYLVPPA CCCCCCCCCEECCCC | 34.30 | 29901268 | |
| 116 | Ubiquitination | FSFESSNMYEIKNSF HHCCCCCCEEEECCC | 4.24 | 29901268 | |
| 120 | Ubiquitination | SSNMYEIKNSFGQRI CCCCEEEECCCCCEE | 10.68 | 29901268 | |
| 149 | Phosphorylation | CGRSRPFTLRITDNV CCCCCCEEEEEECCC | 4.09 | 24719451 | |
| 172 | S-palmitoylation | RPLRCNCCCCPCCLQ CCCCCCCEECCCCCE | 15.43 | - | |
| 173 | S-palmitoylation | PLRCNCCCCPCCLQE CCCCCCEECCCCCEE | 20.56 | - | |
| 174 | S-palmitoylation | LRCNCCCCPCCLQEI CCCCCEECCCCCEEE | 5.45 | - | |
| 176 | S-palmitoylation | CNCCCCPCCLQEIEI CCCEECCCCCEEEEE | 46.88 | - | |
| 177 | S-palmitoylation | NCCCCPCCLQEIEIQ CCEECCCCCEEEEEE | 19.69 | - | |
| 296 | Phosphorylation | DYMFFERTR------ HHHHHCCCC------ | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 149 | T | Phosphorylation | Kinase | PKC | - | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLS2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLS2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of PLS2_HUMAN !! | ||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...